|
FLAVORx, Canada, Launches Massive National Doctor Detailing Education Program FLAVORx, the award winning Biotech Company, has launched a major doctor detailing campaign in Canada to educate doctors on the best way to increase patient's medication compliance for a quick recovery. FLAVORx demand, in Canada, has been unprecedented; thus partnering with many of the largest pharmacies in the country. (PRWEB) October 13, 2005 -- FLAVORx, Maryland’s Biotech Company of the Year that has defined an industry, announced that it is expanding its Canadian Doctor Education force. The FLAVORx doctor-detailers are tasked with educating the Canadian medical community about medicinal non-compliance: adverse impact on patient health because of lack of adherence to medication regimens due to taste and smell. Documented scientific studies confirm medicinal non-compliance is a serious issue, and is not to be ignored.
Earlier this year FLAVORx advanced its scientifically developed biotechnology throughout the Canadian medical community through its presentations at the Primary Care Today Medical Conference, attended by more than 600 Canadian physicians. Beginning in Quebec and expanding to Ontario, British Columbia, Alberta, Nova Scotia and Newfoundland, the FLAVORx doctor-detailing team revealed its multiple strategic platforms, in keeping with the company’s mission to educate clinicians about compliance.
FLAVORx demand is overwhelming. It has partnered with leading Canadian pharmacy chains, most recently Loblaws and Sobeys/Lawton group. FLAVORx already boasts strong Canadian relationships with Le Groupe Jean Coutu, Overwaitea-Sav-on Food Group, London Drugs, Calgary Co-op, Main Drug Mart and other fine pharmacies. The expansive introduction into Canadian pharmacies means that FLAVORx is now available to customers in every province and territory; in Quebec, FLAVORx is trademarked as SAVEURx+.
FLAVORx has advanced the challenge to medicinal compliance by perfecting the methodology that allows pharmacists to turn any bitter or foul-tasting medication into a readily-accepted, flavored liquid. It provides patients of any age with prescription drug or over-the-counter (OTC) medications, a palatable and safe liquid so they can comply with their doctor’s instructions and recover from illness more quickly. In the past decade FLAVORx has safely flavored 50 million prescriptions without a single report of instability, adverse side effects or allergic reaction. FLAVORx prides itself in its safety record and ease-of administration. All FLAVORx flavors are FDA approved, non allergenic, low to no alcohol, dye free, sugar free, sodium free and very concentrated so only a few drops are required to flavor even a large bottle of medication.
FLAVORx President and CEO Kenny Kramm explained that, “With the introduction of FLAVORx, our Canadian retail partners are certainly making a statement to further diversify their pharmacy health care options.” Kramm further stated, “Expanding in Canada is a wonderful opportunity for our fast-growing company.” He hinted that aggressive Cross-Atlantic expansion will soon be within FLAVORx’s reach.
Ashton Maaraba, Senior Vice President, Sales and Canadian Operations, commented that “If not for the dedication of our Canadian partners’ fine management teams, who committed to help convey a message that medicinal non-compliance due to taste or smell is a universal issue throughout the field of medicine—with FLAVORx the solution--then our advancements throughout Canada may not have been realized as rapidly.”
Maaraba, who is spearheading FLAVORx’s Canadian growth and development, has worked closely with senior executives at FLAVORx to deliver the outstanding products and services that have made FLAVORx an Inc. 500 company.
FLAVORx, headquartered in Bethesda, Maryland, USA and is currently located in nearly 30,000 pharmacy locations, including many major hospital pharmacies. Other U.S. chain pharmacies that offer FLAVORx include: Walgreens, Walmart, Rite-Aid, CVS pharmacy, Albertson's, Supervalu, Target, Kroger, Giant Food and Drug, Giant Eagle.
###
|
© Copyright 1997-2008, Vocus PRW Holdings, LLC. |